Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO0503821 pre-filled syringe maintenance treatment in dialysis patients with renal anemia
2004-000081-13Phase 3Completed
- Sponsor
- Roche
- Start
- Feb 2005
- Modality
- Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of epoetin beta in anaemia (2 arms), sponsored by Roche. Primary endpoint: Change in hemoglobin concentration. Started Feb 2005; status: completed.
02
Drugs
epoetin beta
03
Conditions
anaemia
Beyond the preview
Go deeper on 2004-000081-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000081-13.